Avenir Corp Cytosorbents Corp Transaction History

Avenir Corp

$948 Million
Q4 2024

A detailed history of Avenir Corp transactions in Cytosorbents Corp stock. As of the latest transaction made, Avenir Corp holds 3,093,946 shares of CTSO stock, worth $4.02 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

3,093,946

Previous 2,975,559 3.98%

Holding current value

$4.02 Million

Previous $4.46 Million 37.62%

% of portfolio

0.29%

Previous 0.45%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.74 - $1.35 $87,606 - $159,822	118,387 Added 3.98%	3,093,946 $2.78 Million
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.55 $3,707 - $8,210	5,297 Added 0.18%	2,975,559 $4.46 Million
Q2 2024 Aug 14, 2024	SELL	$0.7 - $1.01 $141,703 - $204,458	-202,434 Reduced 6.38%	2,970,262 $2.08 Million
Q1 2024 May 15, 2024	BUY	$0.86 - $1.07 $104,312 - $129,784	121,294 Added 3.98%	3,172,696 $3.01 Million
Q4 2023 Feb 14, 2024	BUY	$1.08 - $1.94 $360,725 - $647,969	334,005 Added 12.29%	3,051,402 $3.39 Million
Q3 2023 Nov 14, 2023	SELL	$1.86 - $4.03 $4,343 - $9,410	-2,335 Reduced 0.09%	2,717,397 $5.11 Million
Q2 2023 Aug 11, 2023	BUY	$2.37 - $3.65 $389,104 - $599,253	164,179 Added 6.42%	2,719,732 $9.76 Million
Q1 2023 May 15, 2023	BUY	$1.79 - $4.17 $194,150 - $452,294	108,464 Added 4.43%	2,555,553 $8.61 Million
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.03 $136,202 - $268,437	132,235 Added 5.71%	2,447,089 $3.79 Million
Q3 2022 Nov 14, 2022	BUY	$1.2 - $2.46 $179,826 - $368,643	149,855 Added 6.92%	2,314,854 $3.15 Million
Q2 2022 Aug 11, 2022	SELL	$1.76 - $3.22 $20,257 - $37,062	-11,510 Reduced 0.53%	2,164,999 $4.74 Million
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $1.12 Million - $1.65 Million	389,234 Added 21.78%	2,176,509 $6.94 Million
Q4 2021 Feb 16, 2022	BUY	$4.05 - $8.11 $1.59 Million - $3.18 Million	391,890 Added 28.08%	1,787,275 $7.49 Million
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $201,852 - $279,997	28,836 Added 2.11%	1,395,385 $11.3 Million
Q2 2021 Aug 13, 2021	BUY	$7.55 - $9.42 $7.61 Million - $9.49 Million	1,007,679 Added 280.79%	1,366,549 $10.3 Million
Q1 2021 May 14, 2021	BUY	$8.23 - $11.48 $1.25 Million - $1.75 Million	152,130 Added 73.59%	358,870 $3.12 Million
Q4 2020 Feb 12, 2021	BUY	$7.65 - $8.98 $126,225 - $148,170	16,500 Added 8.67%	206,740 $1.65 Million
Q3 2020 Nov 13, 2020	BUY	$7.37 - $11.54 $165,972 - $259,880	22,520 Added 13.43%	190,240 $1.52 Million
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $107,513 - $181,300	17,120 Added 11.37%	167,720 $1.66 Million
Q3 2019 Nov 13, 2019	BUY	$4.33 - $7.63 $22,949 - $40,439	5,300 Added 3.65%	150,600 $758,000
Q2 2019 Aug 12, 2019	BUY	$5.92 - $7.78 $343,715 - $451,706	58,060 Added 66.55%	145,300 $960,000
Q1 2019 May 14, 2019	BUY	$6.82 - $8.56 $73,997 - $92,876	10,850 Added 14.2%	87,240 $660,000
Q4 2018 Feb 13, 2019	BUY	$7.05 - $12.64 $240,651 - $431,466	34,135 Added 80.78%	76,390 $617,000
Q3 2018 Nov 14, 2018	BUY	$10.95 - $14.8 $122,475 - $165,538	11,185 Added 36.0%	42,255 $545,000
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $214,383 - $383,714	31,070 New	31,070 $354,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

15.7M

Call Options Held

15.4K

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $56.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avenir Corp, based on Form 13F filings with the SEC.

News

Stay updated on Avenir Corp with notifications on news.

Account